EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors

Sambit K Mohanty iD, Preeti Diwaker, Sourav K Mishra, Shilpy Jha, Anandi Lobo iD, Saroj P Panda, Shivani Sharma, Mohit Kumar, Samriti Arora, Vipra Mallik, Deepika Jain, Ekta Jain und 11 weitere

International Journal of Surgical Pathology · 2024

DOI: 10.1177/10668969231177700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Surgical Pathology, 2024. Verfasst von Sambit K Mohanty und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: Medulloblastoma, Sarcoma, Synovial, Rhabdomyosarcoma, Embryonal, Neuroblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Accurate diagnosis of neuroblastoma may be challenging, especially with limited or inadequate specimen and at the metastatic sites due to overlapping imaging, histopathologic, and immunohistochemical (immunohistochemistry [IHC]; infidelity among various lineage-associated transcription factors eg FLI1, transducin-like enhancer 1, etc) features. GATA3 and ISL1 have recently been described as markers of neuroblastic differentiation. This study aims at determining the diagnostic utility of GATA3 and ISL1 in differentiating neuroblastoma from other pediatric malignant small round blue cell tumors.

Methods

We evaluated GATA3 and ISL1 expression in 74 pediatric small round blue cell tumors that included 23 NMYC -amplified neuroblastomas, 11 EWSR1 -rearranged round cell sarcomas, 7 SYT::SSX1 -rearranged synovial sarcomas, 5 embryonal rhabdomyosarcomas, 10 Wilms tumors (nephroblastomas), 7 lymphoblastic lymphoma, 7 medulloblastoma, and 4 desmoplastic small round cell tumor.

Results

All 23 neuroblastomas (moderate to strong staining in >50% of the tumor cells), 5 T-lymphoblastic lymphomas (moderate to strong staining in 40%-90% of the tumor cells), and 2 desmoplastic small round cell tumors (weak to moderate staining in 20%-30% of the tumor cells) expressed GATA3, while other tumors were negative. ISL1 immunoreactivity was observed in 22 (96%) neuroblastomas (strong staining in in >50% of the tumor cells, n = 17; moderate to strong staining in 26%-50% of the tumor cells, n = 5), 3 embryonal rhabdomyosarcoma (moderate to strong staining in 30%-85% of the tumor cells), 1 synovial sarcoma (weak staining in 20% of the tumor cells), and 7 medulloblastoma (strong staining in 60%-90% of the tumor cells). Other tumors were negative. Overall, GATA3 showed 86% specificity, 100% sensitivity, and 90% accuracy for neuroblastoma, with a positive predictive value (PPV) and negative predictive value (NPV) of 77% and 100%, respectively. ISLI showed 72% specificity, 96% sensitivity, and 81% accuracy for neuroblastoma, with a PPV and NPV of 67% and 97%, respectively. After the exclusion of T-lymphoblastic lymphoma and desmoplastic small round cell tumors, GATA3 had 100% specificity, sensitivity, accuracy, and PPV and NPV for neuroblastoma. Similarly, in pediatric small round blue cell tumors, ISL1 had 100% specificity, sensitivity, accuracy, PPV, and NPV for neuroblastoma, after embryonal rhabdomyosarcoma, synovial sarcoma, and medulloblastoma were excluded.

Conclusions

GATA3 and ISL1 may be valuable in the diagnostic work-up of neuroblastoma and may reliably be used to support the neuroblastic lineage of pediatric small round blue cell tumors. Furthermore, dual positivity helps in challenging scenarios, when there is equivocal imaging, overlapping IHC features, limited specimen, and the lack of facility for a molecular work up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaSarcoma, SynovialRhabdomyosarcoma, EmbryonalNeuroblastomaWilms TumorPrecursor Cell Lymphoblastic Leukemia-LymphomaCerebellar NeoplasmsKidney NeoplasmsHumansChildBiomarkers, TumorDiagnosis, DifferentialGATA3 Transcription Factor

Stichwörter der Autor:innen

GATA3ISL1neuroblastomasmall round blue cell tumor

Substanzen

Biomarkers, TumorGATA3 protein, humanGATA3 Transcription Factor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
  • Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
  • Department of Pathology, University College of Medical Sciences, Delhi, India.
  • Department of Medical Oncology, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
  • Department of Pediatric Oncology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
  • Department of Pathology, AIIMS, Kalyani, West Bengal, India.

ORCID-Profile: Sambit K Mohanty, Anandi Lobo, Arshi Beg

Zitieren

APA

Mohanty, S. K., Diwaker, P., Mishra, S. K., Jha, S., Lobo, A., Panda, S. P., Sharma, S., Kumar, M., Arora, S., Mallik, V., Jain, D., Jain, E., Chakrabarti, I., Varshney, J., Beg, A., Dixit, M., Baisakh, M. R., Naik, S., Sahoo, S. K., …, & Parwani, A. V. (2024). Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969231177700

Vancouver

Mohanty SK, Diwaker P, Mishra SK, Jha S, Lobo A, Panda SP, et al. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors. International Journal of Surgical Pathology. 2024. doi:10.1177/10668969231177700

BibTeX
@article{Mohanty2024,
  author = {Mohanty, Sambit K and Diwaker, Preeti and Mishra, Sourav K and Jha, Shilpy and Lobo, Anandi and Panda, Saroj P and Sharma, Shivani and Kumar, Mohit and Arora, Samriti and Mallik, Vipra and Jain, Deepika and Jain, Ekta and Chakrabarti, Indranil and Varshney, Juhi and Beg, Arshi and Dixit, Mallika and Baisakh, Manas R and Naik, Subhasini and Sahoo, Subrat K and Akgul, Mahmut and Balzer, Bonnie L and Amin, Mahul B and Parwani, Anil V},
  title = {Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors},
  journal = {International Journal of Surgical Pathology},
  year = {2024},
  doi = {10.1177/10668969231177700}
}
Kostenlos starten →